JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 106 filers reported holding JOUNCE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.23 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $6,518 | +66.7% | 3,523 | 0.0% | 0.00% | – |
| Q4 2022 | $3,911 | -51.1% | 3,523 | 0.0% | 0.00% | – |
| Q3 2022 | $8,000 | -38.5% | 3,523 | -20.2% | 0.00% | – |
| Q2 2022 | $13,000 | -27.8% | 4,417 | +68.0% | 0.00% | – |
| Q1 2022 | $18,000 | -18.2% | 2,629 | 0.0% | 0.00% | – |
| Q4 2021 | $22,000 | +10.0% | 2,629 | 0.0% | 0.00% | – |
| Q3 2021 | $20,000 | +11.1% | 2,629 | 0.0% | 0.00% | – |
| Q2 2021 | $18,000 | +12.5% | 2,629 | +73.0% | 0.00% | – |
| Q1 2021 | $16,000 | +45.5% | 1,520 | 0.0% | 0.00% | – |
| Q4 2020 | $11,000 | -8.3% | 1,520 | 0.0% | 0.00% | – |
| Q3 2020 | $12,000 | -20.0% | 1,520 | -28.5% | 0.00% | – |
| Q2 2020 | $15,000 | +50.0% | 2,126 | 0.0% | 0.00% | – |
| Q1 2020 | $10,000 | -60.0% | 2,126 | -29.3% | 0.00% | – |
| Q4 2019 | $25,000 | +150.0% | 3,005 | 0.0% | 0.00% | – |
| Q3 2019 | $10,000 | -33.3% | 3,005 | 0.0% | 0.00% | – |
| Q2 2019 | $15,000 | -21.1% | 3,005 | 0.0% | 0.00% | – |
| Q1 2019 | $19,000 | +171.4% | 3,005 | +54.8% | 0.00% | – |
| Q4 2018 | $7,000 | -46.2% | 1,941 | 0.0% | 0.00% | – |
| Q3 2018 | $13,000 | -13.3% | 1,941 | 0.0% | 0.00% | – |
| Q2 2018 | $15,000 | -72.2% | 1,941 | -19.3% | 0.00% | – |
| Q1 2018 | $54,000 | +25.6% | 2,404 | -28.3% | 0.00% | – |
| Q4 2017 | $43,000 | +2.4% | 3,354 | +23.4% | 0.00% | – |
| Q3 2017 | $42,000 | +100.0% | 2,718 | +75.2% | 0.00% | – |
| Q2 2017 | $21,000 | -22.2% | 1,551 | +26.1% | 0.00% | – |
| Q1 2017 | $27,000 | – | 1,230 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 2,697,829 | $20,045,000 | 88.84% |
| TRV GP III, LLC | 3,048,780 | $22,652,000 | 4.30% |
| Logos Global Management LP | 2,000,000 | $14,860,000 | 1.07% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 208,559 | $1,550,000 | 0.88% |
| PFM Health Sciences, LP | 3,848,822 | $28,597,000 | 0.84% |
| Yorktown Management & Research Co Inc | 113,200 | $841,000 | 0.63% |
| Moloney Securities Asset Management, LLC | 282,250 | $2,097,000 | 0.38% |
| PATHWAY CAPITAL MANAGEMENT, LP | 84,763 | $630,000 | 0.30% |
| Sofinnova Investments, Inc. | 637,347 | $4,735,000 | 0.28% |
| Omega Fund Management, LLC | 275,513 | $2,047,000 | 0.23% |